Home › Marginal Zone Lymphoma › Ohio › Columbus
Marginal Zone Lymphoma clinical trials in Columbus, OH
8 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Epco, Zanu, Ritux for R/R FL or MZL
RecruitingPhase 2
- The Ohio State University Wexner Medical Center, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- The Ohio State University Wexner Medical Center, Columbus
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RecruitingPhase 1
- The Ohio State University, Columbus
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
RecruitingObservational study
- Ohio Health Riverside Methodist Hospital, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
RecruitingPhase 1
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecruitingPhase 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY11 studies
- Seattle, WA9 studies
- Boston, MA9 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Rochester, MN8 studies
- Edison, NJ8 studies
- Houston, TX8 studies
- Miami, FL7 studies
- Denver, CO7 studies
- Nashville, TN7 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.